Correction: BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8<sup>+</sup> cytotoxic T lymphocytes against multiple myeloma: clinical applications.

Bae, Jooeun; Parayath, Neha; Ma, Wenxue; Amiji, Mansoor; Munshi, Nikhil; Anderson, Kenneth C

Correction: BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8⁺ cytotoxic T lymphocytes against multiple myeloma: clinical applications.

Bae, Jooeun; Parayath, Neha; Ma, Wenxue; Amiji, Mansoor; Munshi, Nikhil; Anderson, Kenneth C.

Afiliação

Bae J; Dana-Farber Cancer Institute, Boston, MA, USA. jooeun_bae@dfci.harvard.edu.
Parayath N; Harvard Medical School, Boston, MA, USA. jooeun_bae@dfci.harvard.edu.
Ma W; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Amiji M; University of California San Diego, San Diego, CA, USA.
Munshi N; Northeastern University, Boston, MA, USA.
Anderson KC; Dana-Farber Cancer Institute, Boston, MA, USA.

Leukemia ; 34(7): 1971, 2020 Jul.

Article em En | MEDLINE | ID: mdl-31949267

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google